Travere Therapeutics (NASDAQ:TVTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Travere Therapeutics (TVTX) operate in?

Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Travere Therapeutics Stock (NASDAQ: TVTX) stock price, news, charts, stock research, profile.

Open	$21.50
Close	$21.98
Volume / Avg.	3.09M / 1.42M
Day Range	$21.00 - $22.90
52 Wk Range	5.12 - 25.29
Market Cap	$1.91B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	11.9%
Days to Cover	7.48

Recent News

Lattice Semiconductor, SelectQuote, Radiant Logistics And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

3 Under-the-Radar Healthcare Companies

The healthcare sector is vast and includes everything from massive legacy companies including UnitedHealth Group Inc. (NYSE:UNH) and McKesson Corp. (NYSE:MCK) to tiny upstart pharmaceuticals firms. Investors looking to

MarketBeat

Jim Cramer Says 'Hold On' To Palantir, 'Let Them Walk It Up'; Warns That Travere Therapeutics Is Losing A 'Ton Of Money'

Jim Cramer warns Travere Therapeutics is losing a ton of money. He advises holding onto Palantir as a spec and expects good news from Stanley Black & Decker.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$21.50
Close	$21.98
Volume / Avg.	3.09M / 1.42M
Day Range	$21.00 - $22.90
52 Wk Range	5.12 - 25.29
Market Cap	$1.91B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	11.9%
Days to Cover	7.48

About Travere Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, deve...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Travere Therapeutics (TVTX) stock?

You can purchase shares of Travere Therapeutics (NASDAQ:TVTX) through any online brokerage.

View our list of the best stock brokerages

Who are Travere Therapeutics (TVTX) competitors?

Other companies in Travere Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Centessa Pharmaceuticals (NASDAQ:CNTA), MoonLake (NASDAQ:MLTX), Protagonist Therapeutics (NASDAQ:PTGX) and Mesoblast (NASDAQ:MESO).

What is the forecast, or price target, for Travere Therapeutics (TVTX) stock?

Travere Therapeutics has a consensus price target of $28.63.

What is the current price for Travere Therapeutics (TVTX)?

The stock price for Travere Therapeutics (NASDAQ: TVTX) is $21.98 last updated February 21, 2025 at 4:00 PM EST.

Does Travere Therapeutics (TVTX) pay a dividend?

There are no upcoming dividends for Travere Therapeutics.

When is Travere Therapeutics (NASDAQ:TVTX) reporting earnings?

Travere Therapeutics’s Q1 earnings are confirmed for Monday, May 5, 2025.

Is Travere Therapeutics (TVTX) going to split?

There is no upcoming split for Travere Therapeutics.

What sector and industry does Travere Therapeutics (TVTX) operate in?

Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Travere Therapeutics

Travere Therapeutics (TVTX) Forecast